 "Supriya Lifescience IPO subscribed 74 times on last day of share sale")
The initial public offering (IPO) of Supriya Lifesciences was subscribed 74x on Monday, the concluding day of its issue. The institutional portion was subscribed 33x, the wealthy investor portion 166x, and the retail investor portion 57x.
Supriya Lifesciences had priced its IPO between Rs 265 and Rs 274 per share. The Rs 700-crore IPO comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 500 crore.
The company’s promoter Satish Waman Bagh divested shares worth Rs 500 crore through the IPO. ICICI Securities and Axis Capital were the book-running lead managers.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%